Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELUGOLIX vs REMIFENTANIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELUGOLIX vs REMIFENTANIL: Safety Overview

Metric RELUGOLIX REMIFENTANIL
Total FAERS Reports 20,660 2,733
Deaths Reported 958 210
Death Rate 4.6% 7.7%
Hospitalizations 1,699 995
Average Patient Age 72.4 yrs 50.3 yrs
% Female Patients 1.4% 48.2%
FDA Approval Date Dec 18, 2020 Jan 16, 2018
Manufacturer Sumitomo Pharma America, Inc. Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription